Aadi bioscience to participate in the jefferies healthcare conference

Los angeles , may 29, 2024 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mtor pathway, announced today participation in the jefferies healthcare conference, taking place june 5-6, 2024, in new york. dave lennon, ph.d.
AADI Ratings Summary
AADI Quant Ranking